$PRLB

Proto Labs (PRLB) Q2 2026 Earnings Call Transcript

Proto Labs (PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, with non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8% and adjusted EBITDA was $25.1 million. Q3 revenue guidance is $145 million to $153 million, and full-year 2026 revenue growth guidance was raised to 8% to 10%. Cash and investments were $162.9 million with zero debt.

Original reporting
Published Aug 8, 2026, 4:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 4:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Proto Labs (PRLB) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$PRLBBullishHigh
01

Why it matters

Traders can update models using the newly provided Q3 revenue and non-GAAP EPS ranges and the raised full-year 2026 revenue growth outlook, alongside margin and cash/debt details.

02

Market read

Raised guidance plus margin expansion is the core catalyst, with Europe profitability and European 3D printing softness as key offsets.

03

What to watch

3D printing revenue declined in Europe (down 6.7% revenue), and foreign currency is expected to be an unfavorable $0.4M headwind in Q3, both of which can pressure segment-level momentum.

Relevance 9/10Novelty 9/10Timing: Q2 earnings call with Q3 and FY 2026 guidance issued pre-market today

Background

The article is a transcript-style summary of Proto Labs’ Q2 fiscal 2026 earnings call, including reported results, segment performance, and forward guidance.

Company-level read

Ticker impact

$PRLBBullishHigh confidence
Context

Proto Labs reported Q2 2026 record revenue of $149.3M, expanded non-GAAP EPS to $0.60, and raised full-year revenue growth guidance to 8% to 10%.

Expected impact

Likely bullish near-term bias as raised FY growth and higher EPS guidance can re-rate expectations, tempered by Europe profitability caveat and 3D printing softness in Europe.

Evidence & confidence

The article discloses multiple fresh, decision-relevant datapoints: record revenue, margin expansion (46.8% non-GAAP gross margin), Q3 revenue and EPS guidance ranges, and an increased FY 2026 revenue growth outlook, all tied to management commentary.

Market effects

Strength in aerospace and defense plus telecommunications supports demand read-through for rapid prototyping and manufacturing services, while Europe 3D printing weakness highlights regional mix risk.

Europe shows continued profitability work and a 3D printing revenue decline, which may keep regional sentiment more cautious despite overall European revenue growth.

Improving margins and zero-debt balance sheet can influence investor perception of manufacturing-services peers’ operating leverage and capital discipline.

Counterpoint

Despite raised guidance, network fulfillment revenue was flat and Europe profitability remains a work in process, which could limit upside if margins mean-revert.

Key entities

  • Proto Labs, Inc.

    Reported Q2 2026 record revenue and expanded margins, raised FY 2026 revenue growth guidance, and provided Q3 revenue and non-GAAP EPS guidance.

  • Suresh Krishna

    CEO who discussed strategy execution, including physical AI and Europe profitability transformation.

  • Dan Schumacher

    CFO who highlighted network fulfillment dynamics and provided guidance-related commentary.

Related articles

$PRLBMedAI 8/10

Protolab Shares Up As Q2 Profit Rises, Lifts FY26 Outlook - Update

Protolabs (PRLB) shares rose about 3.3% to $77.64 after the company reported Q2 net income of $9.15 million, up from $4.43 million a year earlier, with revenue at $149.34 million. Protolabs raised its FY2026 revenue growth outlook to 8% to 10% and issued Q3 guidance of $145 million to $153 million revenue and EPS of $0.34 to $0.42.

$PRLBMedAI 8/10

Proto Labs: Q2 Earnings Snapshot

Proto Labs Inc. (PRLB) reported Q2 profit of $9.2 million, or 37 cents per share. Adjusted earnings were 60 cents per share, and revenue was $149.3 million. For the quarter ending September, the company forecast 56 to 64 cents per share. For fiscal Q3, it expects revenue of $145 million to $153 million.

$PRLBHigh

Proto Labs Inc (PRLB): Results of Operations and Financial Condition

Proto Labs Inc (PRLB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prlb-2026731xexx991.htm EX-99.1 Document Exhibit 99.1 Protolabs Reports Financial Results for the Second Quarter of 2026 Record Quarterly Revenue of $149.3 Million, a 10.6% Increase Year-Over-Year GAAP Earnings Per Share of $0.37, Non-GAAP Earnings Per Share of $0.60 Ra

$DLXMed

Deluxe Q2 Earnings Call Highlights

Deluxe (NYSE:DLX) reported Q2 segment results, led by Data Solutions revenue up 21.4% to $82.3M and adjusted EBITDA of $18.1M. Merchant Services revenue rose 6.1% to $107.6M. Print revenue fell 4.3% to $235.9M. Deluxe closed its Celero acquisition on July 31 and raised 2026 guidance: revenue $2.095B-$2.12B, adj. EBITDA $455M-$475M, adj. EPS $3.60-$4.00, and FCF about $200M.